Luigi Petrucci | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2023
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi	HEMATOLOGICAL ONCOLOGY	2023
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)	HAEMATOLOGICA	2023
A prognostic model for patients with lymphoma and COVID-19. a multicentre cohort study	BLOOD ADVANCES	2022
Bing-Neel syndrome coexisting with oligodendroglioma	LEUKEMIA & LYMPHOMA	2022
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL)	LEUKEMIA & LYMPHOMA	2022
Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis	LEUKEMIA & LYMPHOMA	2022
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study	HEMATOLOGICAL ONCOLOGY	2022
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies	BRITISH JOURNAL OF HAEMATOLOGY	2021
MRI versus CT and PET/CT in the preoperative assessment of Hodgkin and non-Hodgkin lymphomas	HEMATO	2021
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study	LEUKEMIA	2020
COVID-19 in patients with hematologic disorders undergoing therapy: perspective of a large referral hematology center in Rome	ACTA HAEMATOLOGICA	2020
Human herpesvirus-8–positive primary effusion lymphoma in HIV-negative patients: single institution case series with a multidisciplinary characterization	CANCER CYTOPATHOLOGY	2020
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy	LEUKEMIA & LYMPHOMA	2020
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma. a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI)	LEUKEMIA & LYMPHOMA	2019
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Patients: A Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy	BLOOD	2019
Lymphomatoid granulomatosis and large granular lymphocyte leukemia, a rare association of two lymphoproliferative disorders	LEUKEMIA & LYMPHOMA	2018
PREDICTIVE FACTORS FOR INFECTIOUS ADVERSE EVENTS IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA TREATED WITH BENDAMUSTINE-RITUXIMAB (R)+/- R MAINTENANCE. RESULTS OF A RETROSPECTIVE ANALYSIS	22nd Congress of the European-Hematology-AssociationHAEMATOLOGICA	2017
EFFICACY, SAFETY AND COST ANALYSIS OF SUBCUTANEOUS VS INTRAVENOUS RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RCHOP	HAEMATOLOGICA	2017
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia	LEUKEMIA RESEARCH	2017